Literature DB >> 8700842

A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

P S Andersen1, A Stryhn, B E Hansen, L Fugger, J Engberg, S Buus.   

Abstract

Specific recognition of peptide/major histocompatibility complex (MHC) molecule complexes by the T-cell receptor is a key reaction in the specific immune response. Antibodies against peptide/MHC complexes would therefore be valuable tools in studying MHC function and T-cell recognition and might lead to novel approaches in immunotherapy. However, it has proven difficult to generate antibodies with the specificity of T cells by conventional hybridoma techniques. Here we report that the phage display technology is a feasible alternative to generate antibodies recognizing specific, predetermined peptide/MHC complexes.

Mesh:

Substances:

Year:  1996        PMID: 8700842      PMCID: PMC39865          DOI: 10.1073/pnas.93.5.1820

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution.

Authors:  A G Amit; R A Mariuzza; S E Phillips; R J Poljak
Journal:  Science       Date:  1986-08-15       Impact factor: 47.728

2.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

3.  Coupling PPD to tumour cells enhances their antigenicity in BCG-primed mice.

Authors:  P J Lachmann; K Sikora
Journal:  Nature       Date:  1978-02-02       Impact factor: 49.962

4.  A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules.

Authors:  A C Olsen; L O Pedersen; A S Hansen; M H Nissen; M Olsen; P R Hansen; A Holm; S Buus
Journal:  Eur J Immunol       Date:  1994-02       Impact factor: 5.532

5.  The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection.

Authors:  A C Young; W Zhang; J C Sacchettini; S G Nathenson
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

6.  Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.

Authors:  W L Tamminen; D Wraith; B H Barber
Journal:  Eur J Immunol       Date:  1987-07       Impact factor: 5.532

7.  Immunization with SV40-transformed cells yields mainly MHC-restricted monoclonal antibodies.

Authors:  B G Froscher; N R Klinman
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

8.  Major histocompatibility complex-restricted antibody reactivity mainly, but not exclusively, directed against cells from male donors.

Authors:  A van Leeuwen; E Goulmy; J J van Rood
Journal:  J Exp Med       Date:  1979-11-01       Impact factor: 14.307

9.  Participation of the major histocompatibility complex in antibody recognition of viral antigens expressed on infected cells.

Authors:  D E Wylie; L A Sherman; N R Klinman
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  37 in total

1.  Modeling the interactions of a peptide-major histocompatibility class I ligand with its receptors. II. Cross-reaction between a monoclonal antibody and two alpha beta T cell receptors.

Authors:  D Rognan; J Engberg; A Stryhn; P S Andersen; S Buus
Journal:  J Comput Aided Mol Des       Date:  2000-01       Impact factor: 3.686

2.  Antibodies to human fetal erythroid cells from a nonimmune phage antibody library.

Authors:  M A Huie; M C Cheung; M O Muench; B Becerril; Y W Kan; J D Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 3.  Selection and characterization of cell binding and internalizing phage antibodies.

Authors:  Yu Zhou; Lequn Zhao; James D Marks
Journal:  Arch Biochem Biophys       Date:  2012-05-22       Impact factor: 4.013

4.  An antibody as surrogate receptor reveals determinants of activity of an innate immune peptide antibiotic.

Authors:  Suvendu Lomash; Sushma Nagpal; Dinakar M Salunke
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

5.  Construction of human naïve Fab library and characterization of anti-met Fab fragment generated from the library.

Authors:  Yongjun Jiao; Ping Zhao; Jin Zhu; Tessa Grabinski; Zhengqing Feng; Xiaohong Guan; R Scot Skinner; Milton D Gross; Rick V Hay; Hiroshi Tachibana; Brian Cao
Journal:  Mol Biotechnol       Date:  2005-09       Impact factor: 2.695

Review 6.  Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens.

Authors:  J M Boulter; B K Jakobsen
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

7.  Epitopes of the class I major histocompatibility complex (MHC-I) recognized in the syngeneic or allogeneic context predominantly linked to antigenic peptide loading to its binding groove.

Authors:  P Nguyen van Binh; H T Duc
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

8.  Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.

Authors:  Susan E Brophy; Lindsay L Jones; Phillip D Holler; David M Kranz
Journal:  Mol Immunol       Date:  2006-12-12       Impact factor: 4.407

9.  The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation.

Authors:  Avital Lev; Kazuyo Takeda; Damien Zanker; Jason C Maynard; Peniel Dimberu; Elizabeth Waffarn; James Gibbs; Nir Netzer; Michael F Princiotta; Len Neckers; Didier Picard; Christopher V Nicchitta; Weisan Chen; Yoram Reiter; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

10.  Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein.

Authors:  Nicholas Veomett; Tao Dao; Hong Liu; Jingyi Xiang; Dmitry Pankov; Leonid Dubrovsky; Joseph A Whitten; Sun-Mi Park; Tatyana Korontsvit; Victoria Zakhaleva; Emily Casey; Michael Curcio; Michael G Kharas; Richard J O'Reilly; Cheng Liu; David A Scheinberg
Journal:  Clin Cancer Res       Date:  2014-05-21       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.